With 0.74 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.12 million shares. The 52-week range on ESRT shows that it touched its highest point at $10.32 and its lowest point at $5.42 during that stretch. It currently has a 1-year price target of $9.90. With its current market cap of 1.64 billion, ESRT has annualized dividend of $0.14 while the current yield stands at 1.40%. Beta for the stock currently stands at 1.31.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ESRT was up-trending over the past week, with a rise of 0.91%, but this was down by -0.30% over a month. Three-month performance surged to 0.81% while six-month performance rose 29.70%. The stock gained 63.95% in the past year, while it has gained 2.89% so far this year. EPS is expected to grow by 1.80% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -5.06%.
Float and Shares Shorts:
At present, 162.06 million ESRT shares are outstanding with a float of 132.82 million shares on hand for trading. On Feb 29, 2024, short shares totaled 7.83 million, which was 4.77% higher than short shares on Jan 31, 2024. In addition to Mr. Anthony E. Malkin as the firm’s Chairman & CEO, Ms. Christina Chiu serves as its President.
Institutional Ownership:
Through their ownership of 89.91% of ESRT’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ESRT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.